Location: | Cambridge |
---|---|
Salary: | £36,924 to £45,163 |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 7th November 2024 |
---|---|
Closes: | 20th November 2024 |
Job Ref: | RB43974 |
We are seeking an enthusiastic, motivated and ambitious postdoctoral Research Associate to join the group of Dr Adam Wilkinson. The Wilkinson Group is relocating from the University of Oxford to join the University of Cambridge and will the Department of Haematology and Cambridge Stem Cell Institute where the Research Associate will be based. Our group's research focusses on expanding and manipulating haematopoietic stem cells (HSCs) ex vivo. We have pioneered highly influential new methods to expand transplantable HSCs long-term ex vivo (Wilkinson et al, Nature, 2019; Igarashi et al, Blood Advances, 2023; Sakurai et al, Nature, 2023) which are now in use worldwide. We have also demonstrated the consequences of CRISPR/Cas9 gene editing on functional HSCs in autologous transplant models (Wilkinson et al, Nature Communications, 2021; Becker et al, Cell Stem Cell, 2023). Our group has significant funding from the Krishnan-Ang Foundation and Dr Wilkinson has recently been awarded a Wellcome Trust Career Development Award.
The relocation of our group to the University of Cambridge provides the opportunity to advertise for a postdoctoral Research Associate who will lead an ongoing project to study the molecular regulation of HSC expansion, differentiation, aging and transformation. Your research will employ ex vivo HSC expansion techniques developed in the Wilkinson Lab. Your studies will also employ CRISPR-based gene editing and screening, and a range of molecular assays.
You will have a PhD in a relevant discipline and at least one first author primary research paper relevant to this post. You will hold a Home Office Personal Licence or equivalent. You will have extensive knowledge of HSC biology and significant experience of working with HSCs. A strong interest in epigenetics, ageing and transformation is desirable. Familiarity with the ex vivo HSC expansion method developed by Dr Wilkinson would be a distinct advantage. Experience of CRISPR/Cas9 gene editing and screening, and molecular assays (RNA-seq, ChIP-seq) is required.
Informal enquiries to Adam Wilkinson at acw63@cam.ac.uk.
Fixed-term: Funds for this post are available until 31 January 2030 in the first instance.
The closing date for applications is 20 November 2024.
Interviews will be held in the week commencing 2 December 2024.
To apply online for this vacancy and to view further information about the role, please click on the ‘Apply’ button above.
This will route you to the University's Web Recruitment System, where you will need to register an account (if you have not already) and log in before completing the online application form.
Please ensure that you upload a cover letter and CV in the Upload section of the online application. The cover letter should outline how you match the criteria for the post and why you are applying for this role. If you upload any additional documents which have not been requested, we will not be able to consider these as part of your application.
Please include details of your referees, including e-mail address and phone number, one of which must be your most recent line manager.
Please quote reference RB43974 on your application and in any correspondence about this vacancy.
The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
Type / Role:
Subject Area(s):
Location(s):